The Transplant Diagnostics market is a subset of the Diagnostics industry, which focuses on the development and commercialization of tests and technologies used to diagnose and monitor transplant patients. These tests are used to detect and monitor the presence of donor-derived cells, as well as to assess the risk of rejection and other complications. Transplant Diagnostics also includes tests used to detect and monitor infections, such as viruses and bacteria, that can be transmitted through transplanted organs. The Transplant Diagnostics market is driven by the increasing number of organ transplants, as well as the need for improved patient outcomes. Additionally, the development of new technologies and tests, such as next-generation sequencing and mass spectrometry, has enabled more accurate and timely diagnosis and monitoring of transplant patients. Some companies in the Transplant Diagnostics market include Abbott, Bio-Rad Laboratories, Becton Dickinson, Cepheid, and Roche Diagnostics. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
